BTIG Downgrades Avrobio Inc. (AVRO) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Avrobio Inc. (AVRO) PT Lowered to $6 at Mizuho Securities
January 5, 2022 5:28 PM ESTMizuho Securities analyst Uy Ear lowered the price target on Avrobio Inc. (NASDAQ: AVRO) to $6.00 (from $28.00) while maintaining a Buy rating.
The analyst commented, "The new clinical data from the Fabry program is disappointing. We update our model to exclude our sales and... More



